Human Biotechnology: Responding to Emerging Dangerous New Human Genetics
By Jesse Reynolds,
Z Magazine
| 03. 31. 2003
As 2003 began, the mainstream press was grappling with a cloning hoax. This January, it launched extended coverage of the 50th anniversary of the identification of DNA's structure. Both events provided golden opportunities to deepen public understanding of the social and political implications of new human genetic and reproductive technologies.
Unfortunately, the media have mostly flubbed these opportunities. The coverage of the Raelians' cloning claims obscured rather than illuminated the critical issues. Early signs on the second media opportunity-a series of carefully planned celebrations throughout the spring-are none too promising. Fortunately, a civil society response to dangerous new human genetic and reproductive technologies is emerging in a number of countries, as witnessed at January's World Social Forum in Brazil.
The year's first human biotechnology media frenzy actually began at the end of December 2002, when a previously obscure alien-chasing sect announced that its scientists had produced the world's first human clone. The initial news reaction appropriately focused on whether the claim could be true. But by the time the Raelians' excuses as to why they were unable to show the...
Related Articles
By Ian Sample, The Guardian | 07.04.2024
Biological models of human embryos that can develop heartbeats, spinal cords and other distinctive features will be governed by a code of practice in Britain to ensure that researchers work on them responsibly.
Made from stem cells, they mimic, to...
By Kevin Davies, Genetic Engineering & Biotechnology News | 06.27.2024
Physician-scientist Matthew Porteus, MD, PhD, has been a mainstay in the genome editing field for more than two decades. He trained at Stanford University Medical School before completing his residency and hematology/oncology fellowship at Boston Children’s Hospital/Dana Farber Cancer Institute...
By Peter Aldhous, Scientific American | 07.02.2024
In June a notice posted on the website of the journal Nature set a new scientific record. It withdrew what is now the most highly cited research paper ever to be retracted.
The study, published in 2002 by Catherine Verfaillie...
By Robert F. Service, Science | 07.04.2024
Image by Ed Uthman from Flickr
Last year, the U.S. Food and Drug Administration (FDA) approved two gene therapy procedures that can treat and, in some cases essentially cure sickle cell disease, a genetic blood disorder that causes pain and...